Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Molecular Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1107-3756 Online ISSN: 1791-244X
Journal Cover
October 2012 Volume 30 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
October 2012 Volume 30 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Inhibition of angiotensin II-induced contraction of human airway smooth muscle cells by angiotensin-(1-7) via downregulation of the RhoA/ROCK2 signaling pathway

  • Authors:
    • Ning Li
    • Ruijun Cai
    • Yi Niu
    • Bin Shen
    • Jian Xu
    • Yuanxiong Cheng
  • View Affiliations / Copyright

    Affiliations: Department of Respiratory Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China, Department of Thoracic Cardiovascular Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China, Department of Kidney Transplantation, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China
  • Pages: 811-818
    |
    Published online on: July 27, 2012
       https://doi.org/10.3892/ijmm.2012.1080
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Sustained renin-angiotensin system (RAS) activation in asthmatic patients plays a crucial role in airway hyperresponsiveness and airflow limitation. Angiotensin II (Ang II), as a key peptide of RAS, contributes to the contraction of human airway smooth muscle by activating the RhoA/Rho-associated coiled-coil containing protein kinase 2 (ROCK2) signaling pathway. Angiotensin-(1-7) [Ang-(1-7)], is a component of the angiotensin I converting enzyme 2 (ACE2)-Ang-(1-7)-Mas axis which counteracts the detrimental effects of the ACE- Ang II-angiotensin type 1 receptor (AT1R) axis in vivo; however, whether Ang-(1-7) can inhibit the effect of Ang II in the contraction of human airway smooth muscle cells (HASMCs) is unknown. In our study, collagen gel lattices and immunofluorescence were used to evaluate the contraction of HASMCs induced by Ang II. Real-time PCR and western blot analysis were performed to confirm the regulatory mechanism and the participating signaling pathway. Ang II caused the contraction of HASMCs; this effect was reversed by Ang‑(1‑7). In addition, irbesartan and A779, which are inhibitors of AT1R and Mas, respectively, attenuated the effect of Ang II and Ang-(1-7). Furthermore, Y-27632, an inhibitor of ROCK2, attenuated the Ang II-induced contraction of HASMCs by blocking the RhoA/ROCK2 signaling pathway which is involved in this contraction, and thus may be a major regulator involved in the basal maintenance of contractility in HASMCs. These data demonstrate that Ang II induces the contraction of HASMCs and that this effect can be reversed by Ang-(1-7), partially through the downregulation of of the RhoA/ROCK2 signaling pathway.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1. 

MI PhillipsEA SpeakmanB KimuraLevels of angiotensin and molecular biology of the tissue renin angiotensin systemsRegul Pept43120199310.1016/0167-0115(93)90403-U8426906

2. 

RP MarshallP GohlkeRC ChambersDC HowellSE BottomsT UngerRJ McAnultyGJ LaurentAngiotensin II and the fibroproliferative response to acute lung injuryAm J Physiol Lung Cell Mol Physiol286L156L164200410.1152/ajplung.00313.200212754187

3. 

E CojocaruIL DumitriuG BogdanM CostuleanuSM SlatineanuG PetrescuInvolvement of angiotensin on adenosine-induced bronchial hyperreactivityPneumologia5819232009(In Romanian)

4. 

A VeerappanAC ReidR EstephanN O’ConnorM Thadani-MuleroM Salazar-RodriguezR LeviRB SilverMast cell renin and a local renin-angiotensin system in the airway: role in bronchoconstrictionProc Natl Acad Sci USA10513151320200810.1073/pnas.070973910518202178

5. 

J ZhongR BasuD GuoFL ChowS ByrnsM SchusterH LoibnerXH WangJM PenningerZ KassiriGY OuditAngiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis and cardiac dysfunctionCirculation122717728201010.1161/CIRCULATIONAHA.110.95536920679547

6. 

M IwaiM HoriuchiDevil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axisHypertens Res32533536200910.1038/hr.2009.7419461648

7. 

JL GrobeAP MeccaM LingisV ShenoyTA BoltonJM MachadoRC SpethMK RaizadaMJ KatovichPrevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7)Am J Physiol Heart Circ Physiol292H736H742200710.1152/ajpheart.00937.200617098828

8. 

V EstebanS Heringer-WaltherA Sterner-KockR de BruinS van den EngelY WangS MezzanoJ EgidoHP SchultheissM Ruiz-OrtegaT Waltherangiotensin-(1-7) and the g protein-coupled receptor MAS are key players in renal inflammationPLoS One4e5406200910.1371/journal.pone.000540619404405

9. 

RA SantosAC Simoes e SilvaC MaricDM SilvaRP MachadoI de BuhrS Heringer-WaltherSV PinheiroMT LopesM Baderangiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor MasProc Natl Acad Sci USA10082588263200310.1073/pnas.143286910012829792

10. 

W LiMJ MooreN VasilievaJ SuiSK WongMA BerneM SomasundaranJL SullivanK LuzuriagaTC GreenoughAngiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirusNature426450454200310.1038/nature0214514647384

11. 

I HammingW TimensML BulthuisAT LelyGJ NavisH van GoorTissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesisJ Pathol203631637200410.1002/path.157015141377

12. 

T WangKS YinKY LiuGJ LuYH LiJD ChenEffect of valsartan on the expression of angiotensin II receptors in the lung of chronic antigen exposure ratsChin Med J (Engl)12123122319200819080339

13. 

N KogataRM TribeR FasslerM WayRH AdamsIntegrin-linked kinase controls vascular wall formation by negatively regulating Rho/ROCK-mediated vascular smooth muscle cell contractionGenes Dev2322782283200910.1101/gad.53540919797768

14. 

Y WangXR ZhengN RiddickM BrydenW BaurX ZhangHK SurksROCK isoform regulation of myosin phosphatase and contractility in vascular smooth muscle cellsCirc Res104531540200910.1161/CIRCRESAHA.108.18852419131646

15. 

K KimuraS EguchiAngiotensin II type-1 receptor regulates RhoA and Rho-kinase/ROCK activation via multiple mechanisms. Focus on ‘Angiotensin II induces RhoA activation through SHP2-dependent dephosphorylation of the RhoGAP p190A in vascular smooth muscle cells’Am J Physiol Cell Physiol297C1059C1061200919741194

16. 

H OhtsuM MifuneGD FrankS SaitoT InagamiS Kim-MitsuyamaY TakuwaT SasakiJD RothsteinH SuzukiSignal-crosstalk between Rho/ROCK and c-Jun NH2-terminal kinase mediates migration of vascular smooth muscle cells stimulated by angiotensin IIArterioscler Thromb Vasc Biol2518311836200510.1161/01.ATV.0000175749.41799.9b15994438

17. 

J LiR KurubaA WilsonX GaoY ZhangS LiInhibition of endothelin-1-mediated contraction of hepatic stellate cells by FXR ligandPLoS One5e13955201010.1371/journal.pone.001395521085652

18. 

R GosensD SchaafsmaH MeursJ ZaagsmaSA NelemansRole of Rho-kinase in maintaining airway smooth muscle contractile phenotypeEur J Pharmacol4837178200410.1016/j.ejphar.2003.10.02714709328

19. 

PV LoGrassoY FengRho kinase (ROCK) inhibitors and their application to inflammatory disordersCurr Top Med Chem9704723200910.2174/15680260978904445219689376

20. 

V Regitz-ZagrosekM NeussJ HolzmeisterC WarneckeE FleckMolecular biology of angiotensin receptors and their role in human cardiovascular diseaseJ Mol Med74233251199610.1007/BF001965778773261

21. 

A BretscherK EdwardsRG FehonERM proteins and merlin: integrators at the cell cortexNat Rev Mol Cell Biol3586599200210.1038/nrm88212154370

22. 

RM TouyzG YaoE VielF AmiriEL SchiffrinAngiotensin II and endothelin-1 regulate MAP kinases through different redox-dependent mechanisms in human vascular smooth muscle cellsJ Hypertens2211411149200410.1097/00004872-200406000-0001515167449

23. 

EA MillarJE NallyNC ThomsonAngiotensin II potentiates methacholine-induced bronchoconstriction in human airway both in vitro and in vivoEur Respir J818381841199510.1183/09031936.95.081118388620948

24. 

YG ZhangXB LiJ ZhangJ HuangC HeC TianY DengH WanD ShresthaYY YangH FanThe I/D polymorphism of angiotensin-converting enzyme gene and asthma risk: a meta-analysisAllergy66197205201110.1111/j.1398-9995.2010.02438.x20880211

25. 

N KitamuraO KaminumaN KobayashiA MoriA contraction assay system using established human bronchial smooth muscle cellsInt Arch Allergy Immunol146Suppl 1S36S39200810.1159/00012605918504405

26. 

N KitamuraO KaminumaT OhtomoN KiyokawaN KobayashiM SukoA MoriEvaluation of cysteinyl leukotriene-induced contraction of human cultured bronchial smooth muscle cellsInt Arch Allergy Immunol149Suppl 18386200910.1159/00021137819494511

27. 

H MatsumotoLM MoirBG OliverJK BurgessM RothJL BlackBE McParlandComparison of gel contraction mediated by airway smooth muscle cells from patients with and without asthmaThorax62848854200710.1136/thx.2006.07047417412779

28. 

JF GianiMM GironacciMC MunozC PenaD TurynFP DominiciAngiotensin-(1 7) stimulates the phosphorylation of JAK2, IRS-1 and Akt in rat heart in vivo: role of the AT1 and Mas receptorsAm J Physiol Heart Circ Physiol293H1154H1163200710.1152/ajpheart.01395.200617496209

29. 

Z SuJ ZimpelmannKD Burnsangiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cellsKidney Int6922122218200610.1038/sj.ki.500150916672906

30. 

N HayashiK YamamotoM OhishiY TataraY TakeyaA ShiotaR OguroY IwamotoM TakedaH RakugiThe counterregulating role of ACE2 and ACE2-mediated angiotensin 1–7 signaling against angiotensin II stimulation in vascular cellsHypertens Res3311821185201020703229

31. 

JP CollisterMD HendelThe role of Ang (1-7) in mediating the chronic hypotensive effects of losartan in normal ratsJ Renin Angiotensin Aldosterone Syst4176179200310.3317/jraas.2003.02814608523

32. 

RM LeeM BaderN AleninaRA SantosYJ GaoC LuMas receptors in modulating relaxation induced by perivascular adipose tissueLife Sci89467472201110.1016/j.lfs.2011.07.01621820449

33. 

BD UhalX LiA XueX GaoA Abdul-HafezRegulation of alveolar epithelial cell survival by the ACE-2/angiotensin 1–7/Mas axisAm J Physiol Lung Cell Mol Physiol301L269L274201121665960

34. 

C Cario-ToumaniantzD Ferland-McColloughG ChadeufG ToumaniantzM RodriguezJP GalizziB LockhartA BrilE ScalbertG LoirandP PacaudRhoA guanine exchange factor expression profile in arteries: Evidence for a Rho kinase-dependent negative feedback in angiotensin II-dependent hypertensionAm J Physiol Cell Physiol302C1394C1404201210.1152/ajpcell.00423.2011

35. 

C SavoiaF TabetG YaoEL SchiffrinRM TouyzNegative regulation of RhoA/Rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive ratsJ Hypertens2310371045200510.1097/01.hjh.0000166845.49850.39

36. 

CD GildnerAL LernerDC HockingFibronectin matrix polymerization increases tensile strength of model tissueAm J Physiol Heart Circ Physiol287H46H53200410.1152/ajpheart.00859.200315001442

37. 

DC HockingJ SottileKJ LangenbachStimulation of integrin-mediated cell contractility by fibronectin polymerizationJ Biol Chem2751067310682200010.1074/jbc.275.14.1067310744764

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Li N, Cai R, Niu Y, Shen B, Xu J and Cheng Y: Inhibition of angiotensin II-induced contraction of human airway smooth muscle cells by angiotensin-(1-7) via downregulation of the RhoA/ROCK2 signaling pathway. Int J Mol Med 30: 811-818, 2012.
APA
Li, N., Cai, R., Niu, Y., Shen, B., Xu, J., & Cheng, Y. (2012). Inhibition of angiotensin II-induced contraction of human airway smooth muscle cells by angiotensin-(1-7) via downregulation of the RhoA/ROCK2 signaling pathway. International Journal of Molecular Medicine, 30, 811-818. https://doi.org/10.3892/ijmm.2012.1080
MLA
Li, N., Cai, R., Niu, Y., Shen, B., Xu, J., Cheng, Y."Inhibition of angiotensin II-induced contraction of human airway smooth muscle cells by angiotensin-(1-7) via downregulation of the RhoA/ROCK2 signaling pathway". International Journal of Molecular Medicine 30.4 (2012): 811-818.
Chicago
Li, N., Cai, R., Niu, Y., Shen, B., Xu, J., Cheng, Y."Inhibition of angiotensin II-induced contraction of human airway smooth muscle cells by angiotensin-(1-7) via downregulation of the RhoA/ROCK2 signaling pathway". International Journal of Molecular Medicine 30, no. 4 (2012): 811-818. https://doi.org/10.3892/ijmm.2012.1080
Copy and paste a formatted citation
x
Spandidos Publications style
Li N, Cai R, Niu Y, Shen B, Xu J and Cheng Y: Inhibition of angiotensin II-induced contraction of human airway smooth muscle cells by angiotensin-(1-7) via downregulation of the RhoA/ROCK2 signaling pathway. Int J Mol Med 30: 811-818, 2012.
APA
Li, N., Cai, R., Niu, Y., Shen, B., Xu, J., & Cheng, Y. (2012). Inhibition of angiotensin II-induced contraction of human airway smooth muscle cells by angiotensin-(1-7) via downregulation of the RhoA/ROCK2 signaling pathway. International Journal of Molecular Medicine, 30, 811-818. https://doi.org/10.3892/ijmm.2012.1080
MLA
Li, N., Cai, R., Niu, Y., Shen, B., Xu, J., Cheng, Y."Inhibition of angiotensin II-induced contraction of human airway smooth muscle cells by angiotensin-(1-7) via downregulation of the RhoA/ROCK2 signaling pathway". International Journal of Molecular Medicine 30.4 (2012): 811-818.
Chicago
Li, N., Cai, R., Niu, Y., Shen, B., Xu, J., Cheng, Y."Inhibition of angiotensin II-induced contraction of human airway smooth muscle cells by angiotensin-(1-7) via downregulation of the RhoA/ROCK2 signaling pathway". International Journal of Molecular Medicine 30, no. 4 (2012): 811-818. https://doi.org/10.3892/ijmm.2012.1080
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team